These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 22653712)
21. Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen. Saure C; Schroeder T; Zohren F; Groten A; Bruns I; Czibere A; Galonska L; Kondakci M; Weigelt C; Fenk R; Germing U; Haas R; Kobbe G Biol Blood Marrow Transplant; 2012 Mar; 18(3):466-72. PubMed ID: 21963618 [TBL] [Abstract][Full Text] [Related]
22. Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation. Jones CV; Copelan EA Future Oncol; 2009 May; 5(4):559-68. PubMed ID: 19450182 [TBL] [Abstract][Full Text] [Related]
23. Hematopoietic stem cell transplantation in the new millennium: report from City of Hope National Medical Center. Molina A; Popplewell L; Kashyap A; Nademanee A Clin Transpl; 2000; ():317-42. PubMed ID: 11512326 [TBL] [Abstract][Full Text] [Related]
30. High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML. O'Meara A; Pabst T; Heim D; Gerull S; Bucher C; Halter J; Arber C; Rovò A; Tichelli A; Gratwohl A; Stern M Bone Marrow Transplant; 2011 May; 46(5):636-40. PubMed ID: 20697364 [TBL] [Abstract][Full Text] [Related]
31. [Results of hematopoietic cell transplantation in the first complete remission in children with acute myeloid leukemia from an intermediate risk group]. SDyshlevaia ZM; Skorobogatova EV; Maschan MA; Shipitsyna IP; Skvortsova IuV; Trakhtman PE; Balashov DN; Pashko IuV; Kurnikova EE; Suntsova EV; Goronkova OV; Solopova GG; Baĭdil'dina DD; Kalinina II; Khachatrian LA; Shneĭder MM; Maschan AA Ter Arkh; 2010; 82(7):34-40. PubMed ID: 20853607 [TBL] [Abstract][Full Text] [Related]
32. Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): how can we improve outcomes in the near future? Phillips GL Leuk Res; 2012 Dec; 36(12):1490-5. PubMed ID: 22954609 [TBL] [Abstract][Full Text] [Related]
34. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis. Novitzky N; Thomas V; du Toit C; McDonald A Biol Blood Marrow Transplant; 2011 Jun; 17(6):875-84. PubMed ID: 20870030 [TBL] [Abstract][Full Text] [Related]
35. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation. Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846 [TBL] [Abstract][Full Text] [Related]
36. Impact of conditioning regimen in allogeneic hematopoetic stem cell transplantation for children with acute myelogenous leukemia beyond first complete remission: a pediatric blood and marrow transplant consortium (PBMTC) study. Sisler IY; Koehler E; Koyama T; Domm JA; Ryan R; Levine JE; Pulsipher MA; Haut PR; Schultz KR; Taylor DS; Frangoul HA Biol Blood Marrow Transplant; 2009 Dec; 15(12):1620-7. PubMed ID: 19896086 [TBL] [Abstract][Full Text] [Related]
37. Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia. Hsieh YY; Hong YC; Hsiao LT; Yu YB; Liu JH; Gau JP; Lin HN; Hsu YN; Chiou TJ; Chen PM; Tzeng CH; Liu CY Eur J Haematol; 2011 Mar; 86(3):237-45. PubMed ID: 21155895 [TBL] [Abstract][Full Text] [Related]
38. Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation. Oran B; Jimenez AM; De Lima M; Popat UR; Bassett R; Andersson B; Borthakur G; Bashir Q; Chen J; Ciurea SO; Jabbour E; Cortes J; Kebriaei P; Khouri IF; Qazilbash MH; Ravandi F; Rondon G; Lu X; Shpall EJ; Champlin RE Biol Blood Marrow Transplant; 2015 Aug; 21(8):1405-1412. PubMed ID: 25840338 [TBL] [Abstract][Full Text] [Related]
39. Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis. Brunet S; Labopin M; Esteve J; Cornelissen J; Socié G; Iori AP; Verdonck LF; Volin L; Gratwohl A; Sierra J; Mohty M; Rocha V J Clin Oncol; 2012 Mar; 30(7):735-41. PubMed ID: 22291086 [TBL] [Abstract][Full Text] [Related]
40. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant. Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]